<DOC>
	<DOCNO>NCT00996788</DOCNO>
	<brief_summary>To study anti free radical &amp; inflammatory effect safety Rebamipide patient suffer dyspepsia due chronic gastritis .</brief_summary>
	<brief_title>Anti Free Radical &amp; Anti Inflammatory Effect &amp; Safety Rebamipide Chronic Gastritis</brief_title>
	<detailed_description />
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Gastritis , Atrophic</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>Patients 1. 18 80 year old 2. symptom dyspepsia need endoscopic examination 3. suffering chronic moderate severe gastritis confirm endoscopically 4. able give informed concern Patients 1. treat drug induce gastritis/ulcer , : NSAID 2. chronic alcoholism , 3. drug abuser 4. contraindicate endoscopy examination 5. erosive ulcerative esophagitis 6. peptic ulcer confirm endoscopy 7. pyloric stenosis 8. active gastrointestinal bleeding 9. major absorption disorder 10. history gastric surgery 11. renal disorder ( creatinine &gt; 2 mg/dL ) 12. liver disease ( SGOT , SGPT , bilirubin ) 13. hematologic disorder ( confirm hemoglobin , erythrocytes , leucocyte , differential blood count ) 14. suffer congestive gastropathy due cirrhosis 15. suffer congestive heart disease 16. pregnant give breast feed 17. hypersensitive Rebamipide 18. treat gastroprotective drug : teprenone , sucralfate . 19. treated acid suppress medicine ( H2A , PPI ) 20. treated antibiotic , mesalazine ( Salofalk )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Patients suffer dyspepsia due chronic gastritis</keyword>
</DOC>